AEHR TEST SYSTEMS (AEHR) Stock Fundamental Analysis
NASDAQ:AEHR • US00760J1088
37.43 USD
-2.37 (-5.95%)
At close: Feb 27, 2026
36.94 USD
-0.49 (-1.31%)
After Hours: 2/27/2026, 8:00:00 PM
We assign a fundamental rating of 4 out of 10 to AEHR. AEHR was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. While AEHR has a great health rating, there are worries on its profitability. AEHR shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
- AEHR had positive earnings in the past year.
- In the past year AEHR has reported a negative cash flow from operations.
- In multiple years AEHR reported negative net income over the last 5 years.
- The reported operating cash flow has been mixed in the past 5 years: AEHR reported negative operating cash flow in multiple years.
1.2 Ratios
- AEHR's Return On Assets of -5.95% is on the low side compared to the rest of the industry. AEHR is outperformed by 66.96% of its industry peers.
- The Return On Equity of AEHR (-6.77%) is worse than 62.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.95% | ||
| ROE | -6.77% | ||
| ROIC | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of AEHR (33.28%) is worse than 64.35% of its industry peers.
- AEHR's Gross Margin has improved in the last couple of years.
- AEHR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.28% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
2. Health
2.1 Basic Checks
- AEHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AEHR has been increased compared to 1 year ago.
- Compared to 5 years ago, AEHR has more shares outstanding
- There is no outstanding debt for AEHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- AEHR has an Altman-Z score of 38.77. This indicates that AEHR is financially healthy and has little risk of bankruptcy at the moment.
- AEHR has a better Altman-Z score (38.77) than 92.17% of its industry peers.
- AEHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 38.77 |
ROIC/WACCN/A
WACC10.59%
2.3 Liquidity
- A Current Ratio of 10.62 indicates that AEHR has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 10.62, AEHR belongs to the top of the industry, outperforming 93.04% of the companies in the same industry.
- AEHR has a Quick Ratio of 5.47. This indicates that AEHR is financially healthy and has no problem in meeting its short term obligations.
- AEHR's Quick ratio of 5.47 is fine compared to the rest of the industry. AEHR outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.62 | ||
| Quick Ratio | 5.47 |
3. Growth
3.1 Past
- The earnings per share for AEHR have decreased strongly by -96.67% in the last year.
- Measured over the past years, AEHR shows a very strong growth in Earnings Per Share. The EPS has been growing by 243890.10% on average per year.
- Looking at the last year, AEHR shows a small growth in Revenue. The Revenue has grown by 4.96% in the last year.
- Measured over the past years, AEHR shows a very strong growth in Revenue. The Revenue has been growing by 21.48% on average per year.
EPS 1Y (TTM)-96.67%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-300%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-26.53%
3.2 Future
- Based on estimates for the next years, AEHR will show a very strong growth in Earnings Per Share. The EPS will grow by 20.92% on average per year.
- The Revenue is expected to grow by 18.08% on average over the next years. This is quite good.
EPS Next Y-185%
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue Next Year-21.32%
Revenue Next 2Y12.27%
Revenue Next 3Y18.08%
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 1247.67 indicates a quite expensive valuation of AEHR.
- AEHR's Price/Earnings ratio is a bit more expensive when compared to the industry. AEHR is more expensive than 60.87% of the companies in the same industry.
- AEHR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.07.
- AEHR is valuated quite expensively with a Price/Forward Earnings ratio of 489.28.
- 64.35% of the companies in the same industry are cheaper than AEHR, based on the Price/Forward Earnings ratio.
- AEHR is valuated expensively when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1247.67 | ||
| Fwd PE | 489.28 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- AEHR's earnings are expected to grow with 20.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
5. Dividend
5.1 Amount
- No dividends for AEHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
37.43
-2.37 (-5.95%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-06 2026-04-06
Inst Owners69.43%
Inst Owner Change3.42%
Ins Owners6.24%
Ins Owner Change1.54%
Market Cap1.15B
Revenue(TTM)53.25M
Net Income(TTM)-8.86M
Analysts76
Price Target25.16 (-32.78%)
Short Float %16.05%
Short Ratio4.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-16.39%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)-5.59%
Min Revenue beat(4)-16.39%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-3.26%
Revenue beat(12)6
Avg Revenue beat(12)-1.32%
Revenue beat(16)8
Avg Revenue beat(16)1.18%
PT rev (1m)0%
PT rev (3m)2.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)-87.49%
EPS NY rev (3m)-247.06%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-32.7%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-19.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1247.67 | ||
| Fwd PE | 489.28 | ||
| P/S | 21.53 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 8.77 | ||
| P/tB | 10.43 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.03
EY0.08%
EPS(NY)0.08
Fwd EY0.2%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.74
BVpS4.27
TBVpS3.59
PEG (NY)N/A
PEG (5Y)0.01
Graham Number1.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.95% | ||
| ROE | -6.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 33.28% | ||
| FCFM | N/A |
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 226.79% | ||
| Cap/Sales | 11.89% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.62 | ||
| Quick Ratio | 5.47 | ||
| Altman-Z | 38.77 |
F-Score4
WACC10.59%
ROIC/WACCN/A
Cap/Depr(3y)210.71%
Cap/Depr(5y)168.36%
Cap/Sales(3y)3.9%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.67%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-300%
EPS Next Y-185%
EPS Next 2Y-28.59%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue 1Y (TTM)4.96%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-26.53%
Revenue Next Year-21.32%
Revenue Next 2Y12.27%
Revenue Next 3Y18.08%
Revenue Next 5YN/A
EBIT growth 1Y-1316.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-243.51%
EBIT Next 3Y87.64%
EBIT Next 5YN/A
FCF growth 1Y-282.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-166.21%
OCF growth 3YN/A
OCF growth 5YN/A
AEHR TEST SYSTEMS / AEHR FAQ
Can you provide the ChartMill fundamental rating for AEHR TEST SYSTEMS?
ChartMill assigns a fundamental rating of 4 / 10 to AEHR.
Can you provide the valuation status for AEHR TEST SYSTEMS?
ChartMill assigns a valuation rating of 1 / 10 to AEHR TEST SYSTEMS (AEHR). This can be considered as Overvalued.
What is the profitability of AEHR stock?
AEHR TEST SYSTEMS (AEHR) has a profitability rating of 1 / 10.
What is the financial health of AEHR TEST SYSTEMS (AEHR) stock?
The financial health rating of AEHR TEST SYSTEMS (AEHR) is 8 / 10.